Canada markets closed

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.1500-0.0100 (-0.86%)
At close: 04:00PM EST
1.1999 +0.05 (+4.34%)
After hours: 06:24PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.1600
Open1.1900
Bid1.0700 x 1400
Ask1.1700 x 800
Day's Range1.1250 - 1.1900
52 Week Range1.0000 - 3.3800
Volume70,726
Avg. Volume189,498
Market Cap69.219M
Beta (5Y Monthly)1.85
PE Ratio (TTM)115.00
EPS (TTM)0.0100
Earnings DateNov 09, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.40
  • GlobeNewswire

    Clearside Biomedical to Participate in Multiple Upcoming Investor and Ophthalmology Conferences in November and December 2022

    ALPHARETTA, Ga., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that management will participate in the following conferences in November and December 2022: BTIG Ophthalmology DayFireside ChatTuesday, November 29, 2022 at 10:30 a.m. ET Piper Sandler 34th Annual Healthcare ConferenceCorporate PresentationThursday, Decemb

  • Simply Wall St.

    Clearside Biomedical Third Quarter 2022 Earnings: Beats Expectations

    Clearside Biomedical ( NASDAQ:CLSD ) Third Quarter 2022 Results Key Financial Results Revenue: US$266.0k (down 91% from...

  • GlobeNewswire

    Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference

    ALPHARETTA, Ga., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, Pharm.D., J.D., Clearside’s President and Chief Executive Officer and Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will participate in a Fireside Chat at the Stifel 2022 Healthcare Conference on Wed